Some of you may not understand the implications of whatI just posted. 12 new drugs, that do NOT need FDA approval from geopolitical fascists. As long as China approves those 12 NEW DRUGS for their population of 3 times larger than those existing in a global dictatorship regime.
You see, the healthier the population of a country so too the healthier economic state of that country leading to lower health cost burdens on the government and greater productivity of it's citizens leading to faster economic growth and prosperity. The CEO of Pfizer, Robert Bourla, stated very clearly, 1 in 3 people will be affected by cancer. That is a huge percentage and huge economic burden within the health care costs of a country. That 1 in 3 as reflected upon the population of China is equivalent to the entire poplulation of the U.S. So to the FDA I merely exercise my limited skills in Mandarin and say FU!
As an anology, in World War 2 it was more effective to wound your opponent than to kill them because a wounded soldier now placed an additional burden upon the opponent and also, subsequent health care costs. Sometimes my dad and his buddies would lose sight of this and utilizing a simply pocket knife, ensure with an enscribed X through the copper cladding of the round during World War 2.
China has already exceeded the U.S. within terms of fusion power, space capabilities, electric vehicles, and now add to that list, NEW DRUGS to fight cancer very effectively....cannabinoid based compounds and as LABS has told has, "advanced derivative products".
The activity that we have witnessed with respect to LABS "entering" the U.S. market is NOT at all the leading edge but rather that geopolitical fascist regime attempting to play catch up now to China. Events associated with LABS, new cannabinoid based drugs, and their global pharma partner are much more advanced that what many investors realize because their limited scope has them focused simply on what was the past, including the FDA.
You must have been watching the wrong hand too closely.